IDS Urine BETA CrossLaps ELISA, Catalog Number AC-05F1. Type of packaging: Cardboard Box containi...
FDA Device Recall #Z-0039-2013 — Class II — August 10, 2012
Recall Summary
| Recall Number | Z-0039-2013 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 10, 2012 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Immunodiagnostics Systems Ltd |
| Location | Boldon Tyne & Wear, N/A |
| Product Type | Devices |
| Quantity | 1 |
Product Description
IDS Urine BETA CrossLaps ELISA, Catalog Number AC-05F1. Type of packaging: Cardboard Box containing plastic bottles. The Urine BETA CrossLaps¿ ELISA is an enzyme immunological test for the quantification of degradation products of C-terminal telopeptides of Type-I collagen in human urine. The Urine BETA CrossLaps¿ ELISA assay is intended for in vitro diagnostic use as an indication of human bone resorption as an aid in A. Monitoring bone resorption changes of 1) Anti-resorptive therapies in postmenopausal women: a) Hormone Replacement Therapies (HRT) with hormones and hormone like drugs b) Bisphosphonate therapies B. Predicting skeletal response (Bone Mineral Density) in postmenopausal women undergoing anti-resorptive therapies a) Hormone Replacement Therapies (HRT) with hormones and hormone like drugs b) Bisphosphonate therapies
Reason for Recall
It has been noted by staff at IDS Inc. that stock of the affected products held at IDS Inc. are labeled with IVD labels although they are not registered for sale as IVDs in the United States. The products should have been labeled as Research Use Only or Investigational use only dependent on their usage.
Distribution Pattern
Nationwide Distribution including NY, CA, ME and CT.
Lot / Code Information
Lot 14541, EXP Nov 2012
Other Recalls from Immunodiagnostics Systems Ltd
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0042-2013 | Class II | IDS-iSYS N-Mid¿ Osteocalcin, Catalog Number IS-... | Aug 10, 2012 |
| Z-0041-2013 | Class II | IDS-iSYS Ostase¿ BAP (Bone Alkaline Phosphatase... | Aug 10, 2012 |
| Z-0045-2013 | Class II | IDS-iSYS Intact PINP Control Set, Catalog Numbe... | Aug 10, 2012 |
| Z-0043-2013 | Class II | IDS-iSYS N-Mid¿ Osteocalcin, Catalog Number IS-... | Aug 10, 2012 |
| Z-0044-2013 | Class II | IDS-iSYS Intact PINP, Catalog Number IS-4000. P... | Aug 10, 2012 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.